企業プロフィール
Akili 株価・ニュース・カタリスト
- ティッカー:
- AKLI
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for AKLI.
企業概要
事業概要
Akili was a digital therapeutics company focused on cognitive treatment and software-based interventions before its public-market decline and restructuring. Its business centered on prescription digital medicine.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ before restructuring, Akili sat in digital health.
ビジネスモデルの特徴
The company depended on product adoption, reimbursement, and the commercialization of software-based therapeutics.
バイオ業界での位置付け
Akili belongs to the historical digital-therapeutics category rather than the current live public-company set.
今後のカタリスト
- Akili’s catalysts are now mostly strategic and closeout-related, with any remaining update focused on how the company’s digital-therapeutics assets are being positioned or monetized. The market will care more about corporate clarity than about a fresh product cycle.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。